Lord, Abbett & Co
DPLO

Lord, Abbett & Co’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Lord, Abbett & Co’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-102,299
Closed -$3.58M – 960
2016
Q2 		$3.58M Buy
102,299
+3,702
+4% +$116K 0.01% 772
2016
Q1 		$2.7M Sell
98,597
-509,330
-84% -$15M 0.01% 805
2015
Q4 		$20.8M Sell
607,927
-377,935
-38% -$11.8M 0.06% 420
2015
Q3 		$28.3M Sell
985,862
-1,543,093
-61% -$66M 0.09% 344
2015
Q2 		$113M Buy
2,528,955
+272,839
+12% +$10.3M 0.3% 72
2015
Q1 		$78M Buy
2,256,116
+1,228,848
+120% +$33.4M 0.2% 140
2014
Q4 		$28.1M Buy
+1,027,268
New +$24.9M 0.07% 388

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lord, Abbett & Co's DPLO Position: Q3 2016 in Review

Lord, Abbett & Co sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2016, closing a stake of 102,299 shares — an estimated $3.58M sold.

Lord, Abbett & Co first reported a position in DPLO in Q4 2014 and held it in 7 quarters. The position peaked at $113M in Q2 2015. 185 funds tracked by Wall St. Rank hold DPLO as of Q3 2016.

  • Lord, Abbett & Co reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2016 after selling out during the quarter.
  • Lord, Abbett & Co sold 102,299 DIPLOMAT PHARMACY, INC. shares in Q3 2016, an estimated $3.58M.
  • Lord, Abbett & Co first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 7 quarters.
  • Lord, Abbett & Co's DIPLOMAT PHARMACY, INC. position peaked at $113M in Q2 2015.
  • 185 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2016.

Based on Lord, Abbett & Co's 13F filing for Q3 2016, filed 10 Nov 2016.